Diong, Roland C.

HRN: 21-51-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/29/2022
07/06/2022
IVT
4.5
Q6
Diabetic Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: